Fog K - Search Results

1

Inflammation kinase PKR phosphorylates α-synuclein and causes α-synuclein-dependent cell death.

Reimer L, Vesterager LB, Betzer C, Zheng J, Nielsen LD, Kofoed RH, Lassen LB, Bølcho U, Paludan SR, Fog K, Jensen PH. Reimer L, et al. Among authors: fog k. Neurobiol Dis. 2018 Jul;115:17-28. doi: 10.1016/j.nbd.2018.03.001. Epub 2018 Mar 1. Neurobiol Dis. 2018. PMID: 29501855

2

Loss of DJ-1 protein stability and cytoprotective function by Parkinson's disease-associated proline-158 deletion.

Rannikko EH, Vesterager LB, Shaik JH, Weber SS, Cornejo Castro EM, Fog K, Jensen PH, Kahle PJ. Rannikko EH, et al. Among authors: fog k. J Neurochem. 2013 Apr;125(2):314-27. doi: 10.1111/jnc.12126. Epub 2013 Jan 15. J Neurochem. 2013. PMID: 23241025 Free article.

3

Antibodies against the C-terminus of α-synuclein modulate its fibrillation.

Sahin C, Lorenzen N, Lemminger L, Christiansen G, Møller IM, Vesterager LB, Pedersen LØ, Fog K, Kallunki P, Otzen DE. Sahin C, et al. Among authors: fog k. Biophys Chem. 2017 Jan;220:34-41. doi: 10.1016/j.bpc.2016.11.002. Epub 2016 Nov 10. Biophys Chem. 2017. PMID: 27863716

4

Polo-like kinase 2 modulates α-synuclein protein levels by regulating its mRNA production.

Kofoed RH, Zheng J, Ferreira N, Lykke-Andersen S, Salvi M, Betzer C, Reimer L, Jensen TH, Fog K, Jensen PH. Kofoed RH, et al. Among authors: fog k. Neurobiol Dis. 2017 Oct;106:49-62. doi: 10.1016/j.nbd.2017.06.014. Epub 2017 Jun 23. Neurobiol Dis. 2017. PMID: 28648742

5

PKR kinase directly regulates tau expression and Alzheimer's disease-related tau phosphorylation.

Reimer L, Betzer C, Kofoed RH, Volbracht C, Fog K, Kurhade C, Nilsson E, Överby AK, Jensen PH. Reimer L, et al. Among authors: fog k. Brain Pathol. 2021 Jan;31(1):103-119. doi: 10.1111/bpa.12883. Epub 2020 Aug 6. Brain Pathol. 2021. PMID: 32716602 Free PMC article.

6

5-HT2A Receptor Binding in the Frontal Cortex of Parkinson's Disease Patients and Alpha-Synuclein Overexpressing Mice: A Postmortem Study.

Rasmussen NB, Olesen MV, Brudek T, Plenge P, Klein AB, Westin JE, Fog K, Wörtwein G, Aznar S. Rasmussen NB, et al. Among authors: fog k. Parkinsons Dis. 2016;2016:3682936. doi: 10.1155/2016/3682936. Epub 2016 Aug 4. Parkinsons Dis. 2016. PMID: 27579212 Free PMC article.

7

Autoimmune antibody decline in Parkinson's disease and Multiple System Atrophy; a step towards immunotherapeutic strategies.

Brudek T, Winge K, Folke J, Christensen S, Fog K, Pakkenberg B, Pedersen LØ. Brudek T, et al. Among authors: fog k. Mol Neurodegener. 2017 Jun 7;12(1):44. doi: 10.1186/s13024-017-0187-7. Mol Neurodegener. 2017. PMID: 28592329 Free PMC article.

8

Establishment of a human induced pluripotent stem cell neuronal model for identification of modulators of A53T α-synuclein levels and aggregation.

Vajhøj C, Schmid B, Alik A, Melki R, Fog K, Holst B, Stummann TC. Vajhøj C, et al. Among authors: fog k. PLoS One. 2021 Dec 21;16(12):e0261536. doi: 10.1371/journal.pone.0261536. eCollection 2021. PLoS One. 2021. PMID: 34932569 Free PMC article.

9

Development of Passive Immunotherapies for Synucleinopathies.

Bergström AL, Kallunki P, Fog K. Bergström AL, et al. Among authors: fog k. Mov Disord. 2016 Feb;31(2):203-13. doi: 10.1002/mds.26481. Epub 2015 Dec 25. Mov Disord. 2016. PMID: 26704735 Review.

10

Selective LRRK2 kinase inhibition reduces phosphorylation of endogenous Rab10 and Rab12 in human peripheral mononuclear blood cells.

Thirstrup K, Dächsel JC, Oppermann FS, Williamson DS, Smith GP, Fog K, Christensen KV. Thirstrup K, et al. Among authors: fog k. Sci Rep. 2017 Aug 31;7(1):10300. doi: 10.1038/s41598-017-10501-z. Sci Rep. 2017. PMID: 28860483 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Search Page

Filters